Ankrd20a11p: A Potential Drug Target for Many Diseases (G391267)

Target Name: ANKRD20A11P

NCBI ID: G391267

ANKRD20A11P

Other Name(s): C21orf81 | ankyrin repeat domain 20 family member A11, pseudogene | Ankyrin repeat domain 20 family member A11, pseudogene | MGC44241

Ankrd20a11p: A Potential Drug Target for Many Diseases

ANKRD20A11P is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the ANKRD20 family of proteins, which are involved in the regulation of actinin, a protein that is involved in many cellular processes, including cell signaling and cytoskeletal organization.

The ANKRD20A11P protein is of particular interest as a potential drug target or biomarker because of its involvement in a variety of cellular processes that are associated with a wide range of diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

One of the key functions of ANKRD20A11P is its role in the regulation of actinin, a protein that is involved in many cellular processes, including cell signaling and cytoskeletal organization.Actinin is a protein that is involved in the regulation of many cellular processes, including the signaling of cell proliferation, differentiation, and survival. It is also involved in the regulation of cytoskeletal organization, which is important for the proper movement of cells and the formation of tissues.

Another function of ANKRD20A11P is its role in the regulation of the actinin-associated protein (AAP) complex. The AAP complex is a protein that is involved in the regulation of actinin, and it is composed of a variety of different proteins, including ANKRD20A11P. This complex plays a role in the regulation of many cellular processes, including cell signaling and cytoskeletal organization.

In addition to its role in the regulation of actinin and the AAP complex, ANKRD20A11P is also involved in the regulation of the cytoskeleton. It is involved in the regulation of the formation and stability of the microtubules, which are the structural elements that make up the cytoskeleton.Microtubules are important for the proper movement of cells and the formation of tissues, and they are involved in many cellular processes, including cell signaling and cytoskeletal organization.

The ANKRD20A11P protein is also involved in the regulation of the cytoskeleton in the regulation of cell division. It is involved in the regulation of the division of cells, including the process of mitosis.Mitosis is the process by which a cell divides, and it is a critical process for the growth and development of all organisms.ANKRD20A11P is involved in the regulation of the division of cells, including the process of mitosis.

In addition to its involvement in the regulation of actinin, the ANKRD20A11P protein is also involved in the regulation of many other cellular processes. It is involved in the regulation of cell signaling, cytoskeletal organization, and cell division.

Given its involvement in so many cellular processes, it is of particular interest as a potential drug target or biomarker. Many diseases, including cancer, neurodegenerative diseases, and respiratory diseases, are associated with the regulation of actinin and the ANKRD20A11P protein. Therefore, ANKRD20A11P may be a useful target for the development of new treatments for these diseases.

Protein Name: Ankyrin Repeat Domain 20 Family Member A11, Pseudogene

The "ANKRD20A11P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A11P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets